CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-29 | Kennedy Joseph T General Counsel | Shares withheld for taxes | −1,360 | $7.50 | $10K | 240,033 |
| 2021-01-29 | Kennedy Joseph T General Counsel | Option exercise · Restricted Stock Units | −26,000 | 0 | ||
| 2021-01-29 | Kennedy Joseph T General Counsel | Option exercise · Restricted Stock Units | −12,733 | 12,733 | ||
| 2021-01-29 | Kennedy Joseph T General Counsel | Option exercise · Restricted Stock Units | −1,806 | 12,636 | ||
| 2021-01-29 | Kennedy Joseph T General Counsel | Option exercise · Restricted Stock Units | −1,806 | 12,636 | ||
| 2021-01-29 | THERO JOHN F President and CEO | Option exercise | +123,666 | 2,879,006 | ||
| 2021-01-29 | THERO JOHN F President and CEO | Option exercise | +72,033 | 2,951,039 | ||
| 2021-01-29 | THERO JOHN F President and CEO | Shares withheld for taxes | −77,460 | $7.50 | $581K | 2,873,579 |
| 2021-01-29 | THERO JOHN F President and CEO | Option exercise | +6,736 | 2,880,315 | ||
| 2021-01-29 | THERO JOHN F President and CEO | Option exercise | +6,736 | 2,887,051 | ||
| 2021-01-29 | THERO JOHN F President and CEO | Shares withheld for taxes | −5,302 | $7.50 | $40K | 2,881,749 |
| 2021-01-29 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −123,666 | 0 | ||
| 2021-01-29 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −72,033 | 72,033 | ||
| 2021-01-29 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −6,736 | 47,152 | ||
| 2021-01-29 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −6,736 | 47,152 | ||
| 2021-01-27 | Ketchum Steven B Chief Scientific Officer | Option exercise | +25,389 | $1.02 | $26K | 556,893 |
| 2021-01-27 | Ketchum Steven B Chief Scientific Officer | Option exercise | +8,332 | $2.50 | $21K | 565,225 |
| 2021-01-27 | Ketchum Steven B Chief Scientific Officer | Option exercise | +5,797 | $2.50 | $14K | 571,022 |
| 2021-01-27 | Ketchum Steven B Chief Scientific Officer | Option exercise | +52,938 | $2.50 | $132K | 623,960 |
| 2021-01-27 | Ketchum Steven B Chief Scientific Officer | Option exercise | +29,427 | $2.50 | $74K | 653,387 |
Page 39 of 67 · 1,339 trades